News January 2007
Generic Drug Programs May Get A Boost
Four-dollar generic drug programs by large retailers like Wal-Mart
and Target may get a boost this legislative session. Consumers would
benefit from the cheaper prescription costs, and local pharmacies
may not be as affected by the price competition as feared.
Rep. Joe Atkins, DFL-Inver Grove Heights, chairman of the House Commerce
and Labor Committee, will propose changes to the 1937 Predatory Pricing
Statue that prevents businesses from selling products below cost with
the intention of eliminating competition.
“I support the law; I don’t intend to undo it,”
said Atkins.
Rather, the bill’s intent is to clarify the law’s relationship
with prescription drug
pricing designed to benefit the consumer, not drive out competition,
he added.
The clarification would only apply to markets where two or more
businesses are competing at below-cost prices.
Through Wal-Mart’s program, 56 of 331 prescriptions priced
at $4 in other states are not available at that price in Minnesota
Wal-Marts. Some of the excluded drugs cost $10 to $20 a prescription,
and include some of the most popular prescription drugs, such as
prednisone.
According to Jerry Prosnick, a pharmacist at Family Drug Mart in
Virginia, customers will find the majority of generic
drugs cheaper at an independent pharmacy rather than through
flat rate programs at other retailers. All drugs currently sold
at $4 are not sold below cost, and may cost less than $4.
Prosnick and other Iron Range pharmacists say they have not lost
business to these programs. Discounting more expensive and popular
drugs may affect that business however. Where only a fraction of
Wal-Mart’s sales are in generic drugs, local pharmacists say
about half of their business is in generics.
In addition, a recent study by the Department of Human Services
found the average cost of dispensing a prescription is $9.59. For
businesses that only deal with prescriptions, these costs cannot
be covered by other product profit.
“Dispensing is a one-time cost, so the question is how often
you are dispensing,” said Atkins.
Pharmacies have already shifted toward three-month prescriptions
to help absorb dispensing costs of generic drugs. According to Atkins,
local pharmacies haven’t lost business for a variety of reasons.
“It appears that the folks who are taking advantage of this
weren’t filling prescriptions to begin with,” said Atkins.
Large retailers don’t seem to be shifting customers away
from small pharmacies, rather they are making new customers. The
issue may also come down to trust. People seek out their local or
family pharmacist because they know and trust them, said Atkins,
and are willing to pay a few dollars more for that security.
The Minnesota Pharmacy Association is taking a more cautious stance.
“We are concerned about that proposal because our pharmacies
in greater Minnesota are already struggling financially,”
said spokesperson Elizabeth Carpenter, who noted the Medicare Part
D program has reduced insurance reimbursements to pharmacists in
the past year.
Carpenter also said that patients who buy their prescriptions at
different pharmacies may run greater risks of drug interactions.
“Pharmacists are put at a huge disadvantage if they don1t
have all of the information about what a patient is taking.”
Source http://www.grandrapids-mn.com/
|